Mayne Pharma Group Limited (MYX) Q4 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Mayne Pharma Group Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.954 Thank you for standing by and welcome to the Maine Pharma Group Limited Fall Year 2026 00:00:04.954 -- 00:00:08.276 results. All participants are in a listen-only mode. 00:00:08.276 -- 00:00:11.699 There will be a presentation followed by a question and answer session. 00:00:11.699 -- 00:00:14.941 If you would like to ask a question via the phone, you will need to press the start key 00:00:14.941 -- 00:00:16.782 followed by the number 1 on your telephone keypad. 00:00:16.782 -- 00:00:21.185 If you would like to ask a question via the webcast, please enter it into the ask a question 00:00:21.185 -- 00:00:24.567 box and click submit. I'd now like to hand the conference over to Mr. 00:00:24.567 -- 00:00:28.929 Aaron Gray, CEO. Please go ahead. 00:00:29.599 -- 00:00:31.440 Thank you, operator. 00:00:31.440 -- 00:00:35.822 Good morning, everyone, and thank you for joining Maine Pharma's fiscal year 26 full-year 00:00:35.822 -- 00:00:40.805 results presentation. I'm Aaron Gray, Chief Executive Officer, and I'm joined today by 00:00:40.805 -- 00:00:44.707 Griffin Buchanan, our Chief Financial Officer, who was appointed in August. 00:00:44.707 -- 00:00:49.430 Today, I'll begin with our fiscal 26 corporate highlights and global footprint. 00:00:49.430 -- 00:00:53.852 Griffin will then take you through the group financial performance before I return to 00:00:53.852 -- 00:00:58.735 walk through each of the three segments, Women's Health, Dermatology and DistributeRx, 00:00:58.735 -- 00:01:00.364 and International. 00:01:00.364 -- 00:01:05.368 And we'll then close with our future growth drivers and fiscal year 27 focus and 00:01:05.368 -- 00:01:10.071 outlook. Then we will open the line for questions. 00:01:11.293 -- 00:01:16.137 Please take a...